NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $789,618 | +0.5% | 7,752 | -0.5% | 0.59% | +3.2% |
Q2 2023 | $785,887 | +41.1% | 7,788 | +28.7% | 0.57% | +32.4% |
Q1 2023 | $556,876 | +15.4% | 6,053 | +13.8% | 0.43% | +0.7% |
Q4 2022 | $482,359 | +21.2% | 5,317 | +1.5% | 0.43% | +11.5% |
Q3 2022 | $398,000 | -16.2% | 5,236 | -6.8% | 0.38% | -9.7% |
Q2 2022 | $475,000 | -6.1% | 5,620 | -2.5% | 0.42% | +12.5% |
Q1 2022 | $506,000 | -4.5% | 5,762 | -5.1% | 0.38% | +3.3% |
Q4 2021 | $530,000 | +1.9% | 6,069 | -4.5% | 0.36% | -8.3% |
Q3 2021 | $520,000 | +1.0% | 6,353 | +12.6% | 0.40% | -1.0% |
Q2 2021 | $515,000 | +1.6% | 5,641 | -5.2% | 0.40% | -5.9% |
Q1 2021 | $507,000 | -13.3% | 5,953 | -4.2% | 0.43% | -15.3% |
Q4 2020 | $585,000 | +5.2% | 6,212 | -3.1% | 0.50% | -0.4% |
Q3 2020 | $556,000 | +1.1% | 6,414 | +1.7% | 0.50% | -5.4% |
Q2 2020 | $550,000 | +15.3% | 6,306 | +8.6% | 0.53% | -9.2% |
Q1 2020 | $477,000 | -14.2% | 5,804 | -1.4% | 0.59% | +4.8% |
Q4 2019 | $556,000 | – | 5,884 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |